Companies Dominating the COPD Treatment Market
- GlaxoSmithKline plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AstraZeneca plc
- Boehringer Ingelheim International GmbH
- Novartis International AG
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Merck & Co., Inc.
- Sunovion Pharmaceuticals Inc.
- Chiesi Farmaceutici S.p.A.
- Circassia Pharmaceuticals plc
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
COPD Treatment Market in 2025 is estimated at USD 20.55 billion.
The global market size was valued at around USD 19.76 billion in 2024 and is projected to grow at a CAGR of around 5%, reaching USD 37.26 billion revenue by 2037.
Asia Pacific is poised to bring in USD 14.53 billion by 2037, driven by growing investments in COPD research and development, addressing healthcare challenges.
The major players in the market include GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V.
